Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Cytopia Limited - Cytopia Commences Second Phase II Study in Brain Cancer
Macular Degeneration - Neurotech Granted Fast Track Designations from the FDA for NT-501 in Two Indications - Retinitis Pigmentosa and Dry Age-Related Macular Degeneration
Myeloma - Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma
Pharmacodynamics - BioCryst Reports Results From BCX-4208 Phase IIa Trial in Subjects With Psoriasis
Regeneron Pharmaceuticals, Inc. - Regeneron's ARCALYST rilonacept Reduced Incidence of Gout Flares by 81 Percent in a Phase 2 Study in Gout Patients Initiating Urate-Lowering Therapy
Alzheimer Disease - Studies from University of California in the area of Alzheimer disease described
Cancer - New findings from University of Washington in the area of cancer described
Clinical Trial Research - New clinical trial research study findings have been reported from University of Nottingham
Gastric Cancer - Research from Y. Kurokawa and co-researchers in the area of gastric cancer published
Hepatitis C Virus - New hepatitis C virus research from F. Hoffmann-LaRoche Ltd. outlined
HIV/AIDS - Reports on HIV/AIDS findings from University of Alabama provide new insights
Lung Cancer - New lung cancer research from Technical University of Munich discussed
Lung Cancer - Scientists at Duke University report research in lung cancer
Magnetic Resonance - Research results from University of Cologne update understanding of magnetic resonance
Monoclonal Antibodies - New monoclonal antibodies research reported from University of Pennsylvania, Medical Department
Oligodendroglioma - New oligodendroglioma study findings recently were published by M.C. Chamberlain and co-researchers
Oligodendroglioma - Studies from N.A. Mohile and colleagues reveal new findings on oligodendroglioma
Ovarian Cancer - Research from J. Konner and co-researchers provides new data on ovarian cancer
Peripheral Artery Disease - Reports from Cambridge University highlight recent research in peripheral artery disease
Pharmacokinetics - Scientists at Pfizer Inc. target pharmacokinetics
Rectal Cancer - Studies from S. Yamamoto et al provide new data on rectal cancer
Solid Cancer - Reports summarize solid cancer study results from P. Gimsing and co-researchers
Squamous Cell Carcinoma - New squamous cell carcinoma study results from T.F. Wang et al described
Surgery - Research from J.M. Berlin et al has provided new information about surgery
Cancer Therapy - New findings from Synta Pharmaceuticals Corporation describe advances in cancer therapy
Enzyme Research - Reports from Karolinska Institut, Department of Medicine add new data to research in enzyme research
Influenza Vaccines - Research results from University of Melbourne, Murdoch Children's Research Institute update understanding of influenza vaccines
Life Sciences - New findings reported from Ohio State University, College of Public Health describe advances in life sciences
Non-Small Cell Lung Cancer Therapy - Study data from National Yang-Ming University provide new insights into non-small cell lung cancer therapy
Small Cell Lung Cancer Therapy - Investigators at Gyeongsang National University, Department of Internal Medicine release new data on small cell lung cancer therapy
Aeris Therapeutics, Inc. - Aeris Therapeutics Announces Phase 2 Trial Results for Non-Surgical Emphysema Treatment
Alzheimer Disease - Anavex completes successful preclinical studies on lead Alzheimers drug candidate
Alzheimer Disease - Pfizer and Medivation Enter Into Global Agreement To Co-develop and Market Dimebon for the Treatment of Alzheimers and Huntingtons Diseases
Amyotrophic Lateral Sclerosis - Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS)
Azaya Therapeutics, Inc. - Azaya Therapeutics Licenses Promising Treatment for Head and Neck Cancers
Dyspareunia - QUATRx Initiates Second Phase 3 Study of OPHENA (Ospemifene Tablets) in Women with Postmenopausal Vaginal Syndrome
Emergent BioSolutions Inc. - Emergent BioSolutions Receives $24 Million Development Contract from the Department of Health and Human Services to Fund Continued Development of Anthrax Monoclonal Antibody
Endometriosis - Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis
Helix Electric - Helix Electric Completes Electrical Contracting Project for Carlsbad Ranch Resort Center
Hepatitis C Virus - InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche
Idera Pharmaceuticals, Inc. - Idera Pharmaceuticals Announces Milestone Payment Under Asthma and Allergy Collaboration
ImClone Systems Incorporated - ERBITUX Phase 3 BMS-099 Lung Cancer Study Secondary Endpoint Update: Overall Survival Results Announced
ImClone Systems Incorporated - ImClone Submits Supplemental Biologics License Application for ERBITUX in First-Line Head and Neck Cancer
Immunization - Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program
Intermittent Claudication - Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD)
Monoclonal Antibodies - Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies
NexMed - Dutton Associates Announces Investment Opinion: NexMed Lowered To Speculative Buy Rating In Research Note By Dutton Associates
Opexa Therapeutics, Inc. - Opexa Therapeutics and Myelin Repair Foundation Partner on Novel Multiple Sclerosis Research Program
Pediatrics - MAP Pharmaceuticals Appoints Alan H. Cohen, M.D., as Vice President, Clinical Development and Medical Affairs, Pulmonary
Pfizer Inc - New Data is Presented on Investigational Oral Anticoagulant Apixaban in Acute Coronary Syndrome Patients
Pharmacokinetics - Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch
Plexxikon Inc. - Plexxikon Initiates Phase 1 Trial for PLX5568
Schizophrenia - Alexza's AZ-004 (Staccato(R) Loxapine) Phase 3 Trial Meets Primary Endpoint of Treating Acute Agitation in Schizophrenic Patients
Sunesis Pharmaceuticals, Inc. - SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases
ZIOPHARM Oncology, Inc. - ZIOPHARM Commences Randomized Phase II Study of Palifosfamide in Soft Tissue Sarcoma
